| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Denmark | 67 | 2024 | 738 | 4.750 |
Why?
|
| Mendelian Randomization Analysis | 22 | 2023 | 967 | 3.830 |
Why?
|
| Myeloproliferative Disorders | 15 | 2024 | 606 | 3.470 |
Why?
|
| Transferrin | 11 | 2018 | 295 | 2.940 |
Why?
|
| Hemochromatosis | 11 | 2017 | 184 | 2.710 |
Why?
|
| Hypothyroidism | 9 | 2024 | 659 | 2.540 |
Why?
|
| Thyroxine | 12 | 2024 | 667 | 2.400 |
Why?
|
| Milk | 6 | 2018 | 449 | 2.390 |
Why?
|
| Lactase | 7 | 2018 | 69 | 2.320 |
Why?
|
| Thrombocythemia, Essential | 6 | 2024 | 105 | 2.280 |
Why?
|
| Ferritins | 8 | 2018 | 590 | 2.230 |
Why?
|
| Hidradenitis Suppurativa | 14 | 2022 | 153 | 2.000 |
Why?
|
| Thyroid Gland | 9 | 2024 | 1173 | 2.000 |
Why?
|
| Polycythemia Vera | 8 | 2024 | 164 | 1.990 |
Why?
|
| Calreticulin | 7 | 2024 | 98 | 1.930 |
Why?
|
| Hyperthyroidism | 5 | 2021 | 295 | 1.780 |
Why?
|
| Thyrotropin | 13 | 2024 | 850 | 1.660 |
Why?
|
| Iodide Peroxidase | 6 | 2024 | 293 | 1.560 |
Why?
|
| Iron Overload | 8 | 2023 | 242 | 1.500 |
Why?
|
| Janus Kinase 2 | 12 | 2024 | 528 | 1.430 |
Why?
|
| Suburban Population | 7 | 2023 | 55 | 1.300 |
Why?
|
| Primary Myelofibrosis | 4 | 2024 | 215 | 1.290 |
Why?
|
| Thyroid Hormones | 3 | 2020 | 389 | 1.190 |
Why?
|
| Psoriasis | 10 | 2022 | 901 | 1.060 |
Why?
|
| Suburban Health | 4 | 2017 | 11 | 1.030 |
Why?
|
| Autoantibodies | 6 | 2023 | 2037 | 1.000 |
Why?
|
| Acne Vulgaris | 3 | 2018 | 302 | 0.960 |
Why?
|
| Diabetes Mellitus, Type 1 | 11 | 2023 | 3338 | 0.940 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2023 | 11729 | 0.930 |
Why?
|
| Lactose Intolerance | 3 | 2018 | 27 | 0.920 |
Why?
|
| Strabismus | 3 | 2022 | 283 | 0.910 |
Why?
|
| Graves Ophthalmopathy | 2 | 2022 | 117 | 0.910 |
Why?
|
| Iron | 9 | 2023 | 1774 | 0.880 |
Why?
|
| Anemia, Pernicious | 1 | 2022 | 19 | 0.860 |
Why?
|
| Dairy Products | 4 | 2019 | 497 | 0.860 |
Why?
|
| Mortality | 4 | 2024 | 2862 | 0.740 |
Why?
|
| Nucleosides | 1 | 2021 | 138 | 0.740 |
Why?
|
| Kidney | 7 | 2023 | 7185 | 0.700 |
Why?
|
| Birth Weight | 4 | 2021 | 2069 | 0.690 |
Why?
|
| Bruch Membrane | 2 | 2016 | 64 | 0.690 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2021 | 182 | 0.680 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2019 | 62 | 0.670 |
Why?
|
| Retinal Drusen | 2 | 2016 | 66 | 0.670 |
Why?
|
| Oxidative Stress | 10 | 2023 | 3082 | 0.660 |
Why?
|
| Goiter | 1 | 2019 | 87 | 0.660 |
Why?
|
| Prediabetic State | 3 | 2020 | 499 | 0.650 |
Why?
|
| Electrocardiography | 14 | 2023 | 6441 | 0.650 |
Why?
|
| Hemostasis | 1 | 2021 | 458 | 0.650 |
Why?
|
| Allostasis | 3 | 2024 | 70 | 0.650 |
Why?
|
| Cross-Sectional Studies | 40 | 2024 | 25032 | 0.640 |
Why?
|
| Genotype | 18 | 2019 | 12944 | 0.640 |
Why?
|
| Glomerular Filtration Rate | 4 | 2023 | 2167 | 0.640 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2021 | 546 | 0.630 |
Why?
|
| Eye Diseases, Hereditary | 2 | 2016 | 117 | 0.630 |
Why?
|
| Middle Aged | 90 | 2023 | 213241 | 0.610 |
Why?
|
| Blood Cells | 1 | 2019 | 310 | 0.610 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2021 | 355 | 0.610 |
Why?
|
| Humans | 168 | 2024 | 743811 | 0.600 |
Why?
|
| Female | 112 | 2024 | 380020 | 0.600 |
Why?
|
| Appendicitis | 1 | 2024 | 645 | 0.600 |
Why?
|
| Male | 106 | 2024 | 349776 | 0.590 |
Why?
|
| Erectile Dysfunction | 1 | 2021 | 436 | 0.590 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2024 | 15518 | 0.560 |
Why?
|
| Maternal Age | 1 | 2019 | 802 | 0.560 |
Why?
|
| Thyroid Function Tests | 4 | 2021 | 286 | 0.560 |
Why?
|
| Abortion, Spontaneous | 2 | 2021 | 544 | 0.550 |
Why?
|
| Aged | 72 | 2023 | 163178 | 0.550 |
Why?
|
| Adult | 81 | 2024 | 213889 | 0.540 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2023 | 2267 | 0.540 |
Why?
|
| Guanosine | 4 | 2021 | 61 | 0.530 |
Why?
|
| Triiodothyronine | 6 | 2024 | 494 | 0.530 |
Why?
|
| Biological Specimen Banks | 4 | 2024 | 709 | 0.520 |
Why?
|
| Smoking | 5 | 2019 | 8984 | 0.510 |
Why?
|
| Spirometry | 1 | 2018 | 863 | 0.510 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 1781 | 0.500 |
Why?
|
| Arthritis, Psoriatic | 1 | 2017 | 215 | 0.500 |
Why?
|
| Population Surveillance | 5 | 2019 | 2614 | 0.490 |
Why?
|
| Inflammation | 10 | 2024 | 10629 | 0.490 |
Why?
|
| Genome-Wide Association Study | 15 | 2024 | 12259 | 0.480 |
Why?
|
| Hip Fractures | 3 | 2018 | 955 | 0.480 |
Why?
|
| Iron, Dietary | 4 | 2023 | 141 | 0.470 |
Why?
|
| Aged, 80 and over | 34 | 2023 | 57744 | 0.470 |
Why?
|
| Depressive Disorder | 3 | 2022 | 3744 | 0.470 |
Why?
|
| Specimen Handling | 2 | 2016 | 694 | 0.470 |
Why?
|
| beta-Thalassemia | 1 | 2016 | 225 | 0.460 |
Why?
|
| Chemistry, Clinical | 3 | 2022 | 63 | 0.460 |
Why?
|
| Thyroidectomy | 1 | 2019 | 879 | 0.450 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2023 | 17439 | 0.440 |
Why?
|
| Educational Status | 3 | 2017 | 2540 | 0.440 |
Why?
|
| Creatinine | 5 | 2023 | 1918 | 0.420 |
Why?
|
| Prenatal Care | 1 | 2019 | 1092 | 0.420 |
Why?
|
| Self Report | 6 | 2024 | 3550 | 0.410 |
Why?
|
| Case-Control Studies | 25 | 2023 | 21733 | 0.410 |
Why?
|
| Laparoscopy | 1 | 2024 | 2148 | 0.410 |
Why?
|
| Young Adult | 37 | 2021 | 56392 | 0.400 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 658 | 0.400 |
Why?
|
| Atrial Fibrillation | 3 | 2019 | 5033 | 0.400 |
Why?
|
| Maternal Exposure | 1 | 2018 | 961 | 0.400 |
Why?
|
| Long QT Syndrome | 1 | 2016 | 453 | 0.400 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1608 | 0.400 |
Why?
|
| Goals | 1 | 2017 | 708 | 0.400 |
Why?
|
| Risk Factors | 30 | 2023 | 72252 | 0.390 |
Why?
|
| Th17 Cells | 1 | 2017 | 766 | 0.390 |
Why?
|
| Social Class | 2 | 2017 | 1997 | 0.390 |
Why?
|
| Kidney Diseases | 2 | 2020 | 2146 | 0.390 |
Why?
|
| Registries | 5 | 2021 | 8090 | 0.380 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 2150 | 0.360 |
Why?
|
| RNA | 5 | 2023 | 2748 | 0.360 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2703 | 0.350 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 641 | 0.350 |
Why?
|
| Albuminuria | 3 | 2023 | 681 | 0.350 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2018 | 858 | 0.350 |
Why?
|
| Rural Population | 6 | 2020 | 2207 | 0.330 |
Why?
|
| Mutation | 14 | 2024 | 29777 | 0.330 |
Why?
|
| Biological Products | 1 | 2017 | 859 | 0.330 |
Why?
|
| Hypertension | 7 | 2020 | 8480 | 0.330 |
Why?
|
| Diabetes Mellitus | 7 | 2020 | 5752 | 0.320 |
Why?
|
| Diabetes, Gestational | 1 | 2018 | 1184 | 0.320 |
Why?
|
| Bone Density | 2 | 2018 | 3460 | 0.320 |
Why?
|
| Cardiovascular Diseases | 10 | 2023 | 15142 | 0.310 |
Why?
|
| Antirheumatic Agents | 1 | 2017 | 1338 | 0.310 |
Why?
|
| Income | 1 | 2017 | 1913 | 0.310 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 2200 | 0.310 |
Why?
|
| Phenotype | 3 | 2021 | 16361 | 0.300 |
Why?
|
| Rural Health | 2 | 2020 | 305 | 0.300 |
Why?
|
| Antidepressive Agents | 2 | 2014 | 2837 | 0.300 |
Why?
|
| Life Style | 2 | 2017 | 3833 | 0.300 |
Why?
|
| Hydroxyurea | 3 | 2023 | 289 | 0.290 |
Why?
|
| Adipokines | 2 | 2019 | 320 | 0.290 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3089 | 0.290 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1004 | 0.280 |
Why?
|
| Vision Screening | 2 | 2019 | 66 | 0.280 |
Why?
|
| Health Surveys | 4 | 2018 | 4036 | 0.270 |
Why?
|
| General Practice | 2 | 2017 | 100 | 0.270 |
Why?
|
| Heart Conduction System | 3 | 2022 | 1047 | 0.270 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 2407 | 0.270 |
Why?
|
| Prevalence | 13 | 2020 | 15211 | 0.270 |
Why?
|
| Body Mass Index | 7 | 2022 | 12718 | 0.260 |
Why?
|
| Urban Population | 1 | 2013 | 2021 | 0.260 |
Why?
|
| Gene Frequency | 3 | 2023 | 3585 | 0.250 |
Why?
|
| Depression | 3 | 2018 | 7760 | 0.250 |
Why?
|
| Genetic Variation | 3 | 2019 | 6535 | 0.250 |
Why?
|
| Interferon-alpha | 4 | 2023 | 895 | 0.250 |
Why?
|
| Visually Impaired Persons | 2 | 2016 | 79 | 0.240 |
Why?
|
| Age Factors | 11 | 2019 | 18355 | 0.240 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 7784 | 0.240 |
Why?
|
| Neoplasms | 9 | 2023 | 21675 | 0.240 |
Why?
|
| Depressive Disorder, Major | 4 | 2021 | 4635 | 0.240 |
Why?
|
| Antihypertensive Agents | 4 | 2017 | 2047 | 0.240 |
Why?
|
| Netherlands | 3 | 2018 | 2170 | 0.240 |
Why?
|
| Overweight | 1 | 2015 | 2371 | 0.240 |
Why?
|
| Isocarboxazid | 1 | 2003 | 7 | 0.230 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3255 | 0.230 |
Why?
|
| Obesity | 5 | 2022 | 12744 | 0.230 |
Why?
|
| Disease Progression | 4 | 2022 | 13273 | 0.220 |
Why?
|
| Somatotypes | 1 | 2023 | 42 | 0.220 |
Why?
|
| Blood Pressure | 5 | 2020 | 8551 | 0.220 |
Why?
|
| Asthma | 2 | 2023 | 6010 | 0.220 |
Why?
|
| Blood Coagulation | 2 | 2021 | 1127 | 0.210 |
Why?
|
| Lymphocytes | 2 | 2024 | 2615 | 0.210 |
Why?
|
| Deoxyguanosine | 2 | 2022 | 84 | 0.210 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 11708 | 0.210 |
Why?
|
| Vascular Diseases | 2 | 2021 | 1161 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 9944 | 0.200 |
Why?
|
| Atrioventricular Node | 1 | 2022 | 182 | 0.200 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 3155 | 0.200 |
Why?
|
| Heart Rate | 5 | 2018 | 4091 | 0.200 |
Why?
|
| Dementia, Vascular | 1 | 2022 | 128 | 0.200 |
Why?
|
| Alleles | 5 | 2020 | 6934 | 0.200 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 120 | 0.200 |
Why?
|
| Antithyroid Agents | 1 | 2021 | 70 | 0.200 |
Why?
|
| Liver Diseases | 2 | 2007 | 1253 | 0.190 |
Why?
|
| Janus Kinase 1 | 1 | 2021 | 104 | 0.190 |
Why?
|
| Appendectomy | 1 | 2024 | 401 | 0.190 |
Why?
|
| Interferons | 2 | 2022 | 706 | 0.190 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 263 | 0.180 |
Why?
|
| Fibrinolysis | 1 | 2021 | 322 | 0.180 |
Why?
|
| Oxidation-Reduction | 4 | 2018 | 2183 | 0.180 |
Why?
|
| Fathers | 1 | 2023 | 358 | 0.180 |
Why?
|
| Odds Ratio | 7 | 2019 | 9848 | 0.180 |
Why?
|
| Cholesterol, HDL | 5 | 2024 | 1813 | 0.180 |
Why?
|
| Sleep | 1 | 2015 | 4619 | 0.180 |
Why?
|
| Megakaryocytes | 1 | 2024 | 545 | 0.180 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2021 | 284 | 0.170 |
Why?
|
| Lung | 1 | 2018 | 9858 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2015 | 3308 | 0.170 |
Why?
|
| Albumins | 1 | 2022 | 568 | 0.170 |
Why?
|
| Blood Coagulation Factors | 1 | 2021 | 355 | 0.170 |
Why?
|
| Proportional Hazards Models | 6 | 2024 | 12354 | 0.170 |
Why?
|
| Pregnancy | 6 | 2021 | 29140 | 0.170 |
Why?
|
| Erythrocyte Count | 1 | 2019 | 163 | 0.170 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2019 | 101 | 0.160 |
Why?
|
| Atrial Premature Complexes | 1 | 2018 | 17 | 0.160 |
Why?
|
| Erythropoiesis | 1 | 2022 | 706 | 0.160 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 154 | 0.160 |
Why?
|
| Neutrophils | 2 | 2024 | 3718 | 0.160 |
Why?
|
| Mannose-Binding Lectin | 1 | 2019 | 150 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 2 | 2016 | 889 | 0.150 |
Why?
|
| Leukocyte Count | 2 | 2019 | 1588 | 0.150 |
Why?
|
| Homocysteine | 1 | 2021 | 647 | 0.150 |
Why?
|
| Prospective Studies | 14 | 2022 | 53250 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 684 | 0.150 |
Why?
|
| Genetic Testing | 4 | 2022 | 3439 | 0.150 |
Why?
|
| Risk | 6 | 2024 | 9677 | 0.150 |
Why?
|
| Risk Assessment | 8 | 2021 | 23327 | 0.150 |
Why?
|
| von Willebrand Factor | 1 | 2021 | 669 | 0.150 |
Why?
|
| Decompression, Surgical | 1 | 2022 | 594 | 0.150 |
Why?
|
| Follow-Up Studies | 7 | 2022 | 39001 | 0.150 |
Why?
|
| Coronary Artery Disease | 3 | 2023 | 6485 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2020 | 350 | 0.140 |
Why?
|
| Thyroid Diseases | 1 | 2020 | 379 | 0.140 |
Why?
|
| Athletic Performance | 1 | 2017 | 95 | 0.140 |
Why?
|
| Poverty Areas | 1 | 2018 | 275 | 0.140 |
Why?
|
| Ventricular Premature Complexes | 1 | 2018 | 111 | 0.140 |
Why?
|
| Quality of Life | 3 | 2020 | 12788 | 0.140 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 710 | 0.140 |
Why?
|
| Receptors, Transferrin | 1 | 2018 | 296 | 0.140 |
Why?
|
| Comorbidity | 6 | 2023 | 10380 | 0.140 |
Why?
|
| Islets of Langerhans | 1 | 2023 | 1350 | 0.140 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 793 | 0.140 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 493 | 0.140 |
Why?
|
| Skin Diseases | 2 | 2016 | 1066 | 0.140 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 595 | 0.140 |
Why?
|
| Stroke | 3 | 2022 | 9975 | 0.140 |
Why?
|
| Fertility | 1 | 2021 | 779 | 0.140 |
Why?
|
| Magnesium | 1 | 2019 | 813 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2020 | 541 | 0.130 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 996 | 0.130 |
Why?
|
| Drug Utilization | 2 | 2014 | 1183 | 0.130 |
Why?
|
| Complement C3 | 1 | 2017 | 461 | 0.130 |
Why?
|
| Cohort Studies | 7 | 2022 | 40545 | 0.130 |
Why?
|
| Fever | 1 | 2003 | 1616 | 0.130 |
Why?
|
| Vital Capacity | 1 | 2018 | 925 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 738 | 0.130 |
Why?
|
| Interleukin-1 | 1 | 2019 | 1263 | 0.130 |
Why?
|
| Incidence | 5 | 2022 | 20948 | 0.130 |
Why?
|
| Zinc | 1 | 2019 | 683 | 0.130 |
Why?
|
| Physical Endurance | 1 | 2017 | 370 | 0.130 |
Why?
|
| Cholesterol, LDL | 4 | 2022 | 2354 | 0.130 |
Why?
|
| Potassium | 1 | 2019 | 1336 | 0.130 |
Why?
|
| Heart Failure | 1 | 2018 | 10896 | 0.120 |
Why?
|
| C-Reactive Protein | 4 | 2022 | 3778 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2024 | 2107 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2021 | 1104 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 1793 | 0.120 |
Why?
|
| Folic Acid | 1 | 2021 | 1293 | 0.120 |
Why?
|
| Diet | 4 | 2019 | 7930 | 0.120 |
Why?
|
| Cytokines | 2 | 2019 | 7324 | 0.120 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 1181 | 0.120 |
Why?
|
| 5' Untranslated Regions | 1 | 2015 | 249 | 0.120 |
Why?
|
| Sex Factors | 6 | 2019 | 10394 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 13980 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 6030 | 0.120 |
Why?
|
| Waist Circumference | 1 | 2017 | 917 | 0.110 |
Why?
|
| Medicine | 1 | 2022 | 945 | 0.110 |
Why?
|
| Urine | 1 | 2015 | 370 | 0.110 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2016 | 392 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 582 | 0.110 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 15526 | 0.110 |
Why?
|
| Estradiol | 1 | 2021 | 2017 | 0.110 |
Why?
|
| Angina Pectoris | 1 | 2017 | 977 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2017 | 1654 | 0.110 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 1740 | 0.110 |
Why?
|
| Gallstones | 1 | 2015 | 286 | 0.110 |
Why?
|
| Physical Fitness | 1 | 2017 | 732 | 0.110 |
Why?
|
| Random Allocation | 1 | 2017 | 2429 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2008 | 1366 | 0.110 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3264 | 0.110 |
Why?
|
| Exons | 1 | 2019 | 2438 | 0.110 |
Why?
|
| Demography | 1 | 2017 | 1653 | 0.110 |
Why?
|
| Microcirculation | 1 | 2017 | 1287 | 0.110 |
Why?
|
| Amblyopia | 1 | 2014 | 134 | 0.110 |
Why?
|
| Blood | 1 | 2015 | 596 | 0.110 |
Why?
|
| Age Distribution | 4 | 2014 | 2899 | 0.110 |
Why?
|
| Thrombophilia | 1 | 2015 | 305 | 0.110 |
Why?
|
| Epidemics | 1 | 2018 | 523 | 0.110 |
Why?
|
| Genetics, Population | 1 | 2017 | 933 | 0.110 |
Why?
|
| Quality Control | 1 | 2015 | 841 | 0.110 |
Why?
|
| Self Care | 1 | 2017 | 786 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2024 | 77410 | 0.100 |
Why?
|
| Photography | 1 | 2015 | 519 | 0.100 |
Why?
|
| Health Services Research | 1 | 2020 | 1836 | 0.100 |
Why?
|
| Hemoglobins | 1 | 2018 | 1531 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1347 | 0.100 |
Why?
|
| Genetic Linkage | 1 | 2017 | 2419 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2023 | 1349 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 4251 | 0.100 |
Why?
|
| Fluorescein Angiography | 1 | 2016 | 940 | 0.100 |
Why?
|
| Animals | 10 | 2021 | 168660 | 0.100 |
Why?
|
| Epidemiologic Studies | 1 | 2015 | 676 | 0.100 |
Why?
|
| Research Design | 3 | 2017 | 5983 | 0.100 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2013 | 426 | 0.100 |
Why?
|
| Coronary Circulation | 1 | 2017 | 1572 | 0.100 |
Why?
|
| Spinal Fractures | 1 | 2018 | 696 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2019 | 2016 | 0.100 |
Why?
|
| Sports | 1 | 2017 | 688 | 0.100 |
Why?
|
| Triglycerides | 2 | 2022 | 2453 | 0.100 |
Why?
|
| Infant, Newborn | 6 | 2020 | 25609 | 0.100 |
Why?
|
| Testosterone | 1 | 2021 | 2297 | 0.100 |
Why?
|
| Saliva | 1 | 2015 | 809 | 0.100 |
Why?
|
| Gestational Age | 1 | 2019 | 3488 | 0.100 |
Why?
|
| Personality Inventory | 1 | 2014 | 1030 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2020 | 1859 | 0.090 |
Why?
|
| Length of Stay | 1 | 2024 | 6311 | 0.090 |
Why?
|
| Health Status | 1 | 2024 | 4031 | 0.090 |
Why?
|
| Alzheimer Disease | 2 | 2021 | 8035 | 0.090 |
Why?
|
| Adolescent | 9 | 2021 | 85729 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 1955 | 0.090 |
Why?
|
| ROC Curve | 1 | 2017 | 3527 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2018 | 1608 | 0.090 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 979 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1789 | 0.090 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2794 | 0.080 |
Why?
|
| Metalloendopeptidases | 2 | 2002 | 396 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2015 | 788 | 0.080 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 866 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2369 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 1848 | 0.080 |
Why?
|
| Anthropometry | 1 | 2013 | 1348 | 0.080 |
Why?
|
| Vision Disorders | 1 | 2016 | 1055 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6539 | 0.080 |
Why?
|
| Dietary Supplements | 2 | 2018 | 3292 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3307 | 0.080 |
Why?
|
| DNA Damage | 3 | 2023 | 2429 | 0.080 |
Why?
|
| Insulin | 3 | 2019 | 6584 | 0.080 |
Why?
|
| Leukocytes | 1 | 2016 | 2044 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1832 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2217 | 0.080 |
Why?
|
| Dermatitis, Atopic | 1 | 2014 | 654 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 1438 | 0.070 |
Why?
|
| Physical Examination | 1 | 2013 | 1235 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15067 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2018 | 1188 | 0.070 |
Why?
|
| Clinical Trials as Topic | 3 | 2021 | 7908 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 12243 | 0.070 |
Why?
|
| Body Composition | 1 | 2015 | 2401 | 0.070 |
Why?
|
| Anemia | 1 | 2015 | 1502 | 0.070 |
Why?
|
| Calcium | 1 | 2019 | 5755 | 0.070 |
Why?
|
| Asymptomatic Diseases | 2 | 2019 | 552 | 0.070 |
Why?
|
| Vitamin D | 1 | 2019 | 3222 | 0.070 |
Why?
|
| Insulin Resistance | 2 | 2016 | 3863 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2018 | 5002 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3587 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2009 | 674 | 0.060 |
Why?
|
| Heart | 1 | 2018 | 4460 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5532 | 0.060 |
Why?
|
| Homozygote | 2 | 2007 | 1787 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 2877 | 0.060 |
Why?
|
| Endpoint Determination | 1 | 2007 | 601 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2017 | 3187 | 0.060 |
Why?
|
| Retina | 1 | 2015 | 2612 | 0.060 |
Why?
|
| Hydrocortisone | 2 | 2022 | 1826 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3608 | 0.060 |
Why?
|
| Hospitals | 2 | 2015 | 3953 | 0.060 |
Why?
|
| Mass Screening | 1 | 2019 | 5251 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2134 | 0.060 |
Why?
|
| Motor Activity | 1 | 2013 | 2714 | 0.060 |
Why?
|
| Heterozygote | 2 | 2007 | 2803 | 0.060 |
Why?
|
| Molecular Epidemiology | 1 | 2005 | 467 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 1670 | 0.060 |
Why?
|
| Prognosis | 2 | 2021 | 29052 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14714 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2007 | 577 | 0.050 |
Why?
|
| Colon | 2 | 2002 | 1772 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2018 | 3445 | 0.050 |
Why?
|
| Membrane Proteins | 3 | 2008 | 7880 | 0.050 |
Why?
|
| Reference Values | 3 | 2021 | 4974 | 0.050 |
Why?
|
| Defense Mechanisms | 1 | 2022 | 178 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2021 | 2971 | 0.050 |
Why?
|
| Sex Determination Analysis | 1 | 2021 | 44 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2024 | 15281 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4931 | 0.050 |
Why?
|
| Cities | 1 | 2024 | 512 | 0.050 |
Why?
|
| Child | 5 | 2023 | 77637 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3537 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10179 | 0.050 |
Why?
|
| Elastin | 1 | 2022 | 306 | 0.050 |
Why?
|
| Histamine | 1 | 2022 | 507 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2021 | 403 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 3965 | 0.050 |
Why?
|
| Carotid Artery Diseases | 1 | 2007 | 875 | 0.050 |
Why?
|
| Family Health | 1 | 2005 | 1280 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2016 | 4584 | 0.040 |
Why?
|
| Intestinal Mucosa | 2 | 2002 | 3038 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6356 | 0.040 |
Why?
|
| Anesthesia, Local | 1 | 2021 | 275 | 0.040 |
Why?
|
| Privacy | 1 | 2021 | 238 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2022 | 642 | 0.040 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2019 | 87 | 0.040 |
Why?
|
| Tibial Arteries | 1 | 2018 | 57 | 0.040 |
Why?
|
| DNA | 2 | 2023 | 7295 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2018 | 6593 | 0.040 |
Why?
|
| Blood Platelets | 2 | 2022 | 2509 | 0.040 |
Why?
|
| Laboratories | 1 | 2022 | 462 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4183 | 0.040 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2021 | 349 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2022 | 974 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2022 | 695 | 0.040 |
Why?
|
| Oculomotor Muscles | 1 | 2021 | 370 | 0.040 |
Why?
|
| Arteries | 1 | 2022 | 1119 | 0.040 |
Why?
|
| Competitive Behavior | 1 | 2017 | 74 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2018 | 369 | 0.040 |
Why?
|
| Cicatrix | 1 | 2022 | 763 | 0.040 |
Why?
|
| Visual Acuity | 2 | 2016 | 2525 | 0.030 |
Why?
|
| Water Supply | 1 | 2017 | 214 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 717 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 848 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 2019 | 2961 | 0.030 |
Why?
|
| Nitriles | 1 | 2020 | 953 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1999 | 792 | 0.030 |
Why?
|
| Neonatal Screening | 1 | 2019 | 590 | 0.030 |
Why?
|
| Suicide, Attempted | 1 | 2003 | 1218 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2019 | 880 | 0.030 |
Why?
|
| Autopsy | 1 | 2018 | 1020 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 2015 | 206 | 0.030 |
Why?
|
| Suppuration | 1 | 2014 | 56 | 0.030 |
Why?
|
| Unemployment | 1 | 2016 | 214 | 0.030 |
Why?
|
| Teaching | 1 | 2022 | 1173 | 0.030 |
Why?
|
| Antioxidants | 1 | 2022 | 1658 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 2015 | 473 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 1542 | 0.030 |
Why?
|
| Hand Dermatoses | 1 | 2014 | 61 | 0.030 |
Why?
|
| Bilirubin | 1 | 2015 | 425 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2015 | 367 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2022 | 2132 | 0.030 |
Why?
|
| China | 1 | 2019 | 2243 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 4422 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2018 | 1000 | 0.030 |
Why?
|
| Calcinosis | 1 | 2022 | 1495 | 0.030 |
Why?
|
| Logistic Models | 2 | 2018 | 13404 | 0.030 |
Why?
|
| Epitopes | 1 | 2020 | 2570 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 593 | 0.030 |
Why?
|
| Microvessels | 1 | 2017 | 544 | 0.030 |
Why?
|
| Pruritus | 1 | 2016 | 361 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 819 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 302 | 0.030 |
Why?
|
| Immunity | 1 | 2019 | 1013 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2020 | 9139 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2015 | 675 | 0.030 |
Why?
|
| Bipolar Disorder | 2 | 2021 | 5027 | 0.030 |
Why?
|
| Platelet Count | 1 | 2015 | 780 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 866 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2019 | 6259 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2022 | 1920 | 0.030 |
Why?
|
| Diet, Mediterranean | 1 | 2018 | 700 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1988 | 0.030 |
Why?
|
| Eczema | 1 | 2014 | 231 | 0.020 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 359 | 0.020 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 295 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 715 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2018 | 1358 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 1311 | 0.020 |
Why?
|
| Energy Intake | 1 | 2018 | 2149 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2016 | 1061 | 0.020 |
Why?
|
| Linear Models | 1 | 2020 | 5952 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2021 | 63042 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2020 | 1970 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2002 | 1911 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 6620 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2018 | 1158 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 2942 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2002 | 2304 | 0.020 |
Why?
|
| ADAM Proteins | 2 | 2002 | 243 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 1376 | 0.020 |
Why?
|
| Observer Variation | 1 | 2015 | 2592 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2019 | 6457 | 0.020 |
Why?
|
| Infant | 2 | 2023 | 35122 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3208 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2298 | 0.020 |
Why?
|
| Fasting | 1 | 2014 | 1590 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4477 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2077 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 2945 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2021 | 2789 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6188 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2014 | 851 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 1178 | 0.020 |
Why?
|
| Pain | 1 | 2021 | 4987 | 0.020 |
Why?
|
| Disease | 1 | 2012 | 680 | 0.020 |
Why?
|
| Genomics | 1 | 2022 | 5714 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40038 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 3337 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1999 | 2428 | 0.020 |
Why?
|
| Aging | 1 | 2023 | 8655 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2008 | 20827 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2575 | 0.010 |
Why?
|
| BRCA2 Protein | 1 | 2008 | 794 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 2375 | 0.010 |
Why?
|
| Skin | 1 | 2016 | 4372 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2007 | 640 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1157 | 0.010 |
Why?
|
| Exercise | 1 | 2018 | 5611 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8337 | 0.010 |
Why?
|
| Genital Neoplasms, Female | 1 | 2007 | 523 | 0.010 |
Why?
|
| BRCA1 Protein | 1 | 2008 | 1148 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18027 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13869 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2007 | 1203 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 9718 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2018 | 6865 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 21824 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13691 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2002 | 1382 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4326 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 40964 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1999 | 1188 | 0.010 |
Why?
|
| United States | 1 | 2019 | 69859 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4749 | 0.010 |
Why?
|
| Colonoscopy | 1 | 1999 | 1367 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81154 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 3749 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 11360 | 0.010 |
Why?
|
| Biopsy | 1 | 1999 | 6750 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 13809 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 18107 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1999 | 13028 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 11059 | 0.000 |
Why?
|